Potassium channel inhibitors

Details for Australian Patent Application No. 2005269505 (hide)

Owner Merck Sharp & Dohme Corp.

Inventors Dinsmore, Christopher J.; Trotter, B. Wesley; Wu, Zhicai; Bilodeau, Mark T.; Hartnett, John; Bergman, Jeffrey M.; Manley, Peter; Neilson, Lou Anne

Agent Spruson & Ferguson

Pub. Number AU-B-2005269505

PCT Pub. Number WO2006/014877

Priority 60/592,242 29.07.04 US

Filing date 25 July 2005

Wipo publication date 9 February 2006

Acceptance publication date 16 June 2011

International Classifications

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/444 (2006.01)

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

C07D 403/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Event Publications

22 February 2007 PCT application entered the National Phase

  PCT publication WO2006/014877 Priority application(s): WO2006/014877

28 January 2010 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

16 June 2011 Application Accepted

  Published as AU-B-2005269505

13 October 2011 Standard Patent Sealed

11 October 2012 Alteration of Name

  The name of the patentee has been altered to Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005269506-Nutritional compositions and methods for treating or preventing osteoporosis

2005269499-Collapsible resistance exercise device